APL Bioengineering is a peer-reviewed english-language open-access journal published by AIP Publishing LLC in United States, operating under an open-access model since 2017. The journal covers Chemical technology: Biotechnology and Medicine (General): Medical technology.
Authors are required to pay an article processing charge to publish in APL Bioengineering; refer to the journal's APC page for the current rate. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, APL Bioengineering has published 583 articles. Articles are minted with DOIs through the prefix 10.1063.
Keywords
biology, bioengineering, biophysics, biomedicine
At a glance
- Publisher
- AIP Publishing LLC
- Country
- United States
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Peer review
- OA since
- 2017
- Review time
- 19 weeks
- DOI prefix
10.1063
ISSN
- electronic
- 2473-2877
Frequently asked questions
Is APL Bioengineering peer-reviewed?
Yes — APL Bioengineering operates a Peer review review process.
Does APL Bioengineering charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate.
What subjects does APL Bioengineering publish?
APL Bioengineering publishes research in Chemical technology: Biotechnology and Medicine (General): Medical technology.
What languages does APL Bioengineering accept?
APL Bioengineering accepts manuscripts in English.
What is the ISSN of APL Bioengineering?
ISSN:
2473-2877 (electronic).How do I submit a manuscript to APL Bioengineering?
Submit through the journal's official portal: visit submission page →
How long does peer review take at APL Bioengineering?
Average time from submission to publication is approximately 19 weeks.